mCherry mRNA (N1-Me-Pseudo U)
| Catalog No. | ON-481 |
| Purity | N/A |
| Source | N/A |
mCherry mRNA (N1-Me-Pseudo U)
mCherry mRNA (N1-Me-Pseudo U) - M (Molecular Biology) / 1mg / centrifuge tube is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Details
Details
mCherry mRNA (N1-Me-Pseudo U) is a chemically modified messenger RNA molecule that can express red fluorescent protein mCherry . It is mainly used in biomedical research for gene expression detection, evaluating transfection efficiency, and drug delivery studying. Through optimization of co-transcription with cap addition, it has high translation efficiency and stability, and is suitable for experiments in cells and animals. Additionally, N1-Me-pseudo U modification enhances translation efficiency and reduces immunogenicity.
Specifications
Specifications
-
Catalog No.ON-481
-
SourceN/A
-
PurityN/A
Documentation
Documentation
mCherry mRNA (N1-Me-Pseudo U) is a chemically modified messenger RNA molecule that can express red fluorescent protein mCherry . It is mainly used in biomedical research for gene expression detection, evaluating transfection efficiency, and drug delivery studying. Through optimization of co-transcription with cap addition, it has high translation efficiency and stability, and is suitable for experiments in cells and animals. Additionally, N1-Me-pseudo U modification enhances translation efficiency and reduces immunogenicity.
-
Catalog No.ON-481
-
SourceN/A
-
PurityN/A
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
